← Eichor
Study identifier: NCT02647827 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Acupuncture or Metformin for Insulin Resistance in Women With PCOS

Condition: Polycystic Ovary Syndrome · Insulin Resistance · Hyperandrogenism  ·  Sponsor: Karolinska Institutet

PhasePhase 2
Planned participants303
Who can joinFemale, 18 Years to 40 Years
Healthy volunteersYes

About this study

The hypothesis is that acupuncture is equally effective as metformin (both treatments combined with lifestyle management) in improving whole body glucose homeostasis in insulin resistant women with polycystic ovary syndrome (PCOS), and that both are superior to lifestyle management alone. The investigators hypothesize that acupuncture and metformin induce ovulation and improve hyperandrogenism, as well as health related quality of life (HRQoL) and symptoms of anxiety and depression. Although equally effective (acupuncture and metformin), the investigators hypothesize that acupuncture is associated with less negative side-effects. The investigators also hypothesize that these treatments have the potential to restore epigenetic and molecular alterations in target tissues (endometrial-, adipose-, and skeletal muscle tissue) and thus have the potential to prevent the development of type 2 diabetes (T2D).

This description comes directly from the study's public registry record.

Talk to the study team

Elisabet Stener-Victorin, PhD  ·  +46705643655  ·  elisabet.stener-victorin@ki.se

Berit Legerstam, Study nurse  ·  +46851773782  ·  berit.legerstam@karolinska.se

Always discuss trial participation with your own doctor first.

Locations (2)

Peking UniversityBeijing, ChinaRecruiting
Karolinska University HospitalStockholm, SwedenRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT02647827